![Targeting Disease Progression in Crohn's Disease: Fighting an Unrelenting Enemy - European Medical Journal Targeting Disease Progression in Crohn's Disease: Fighting an Unrelenting Enemy - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2018/01/New-Website-Photographs-.8-940x564.jpg)
Targeting Disease Progression in Crohn's Disease: Fighting an Unrelenting Enemy - European Medical Journal
![12th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology 12th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology](https://www.esp-pathology.org/_Resources/Persistent/ac53b796218c5b837763c09492b2107fa2791497/170907_v2_ECCO%2717%20Web%20banner_150x100.jpg)
12th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology
![EJC | European Journal of Cancer | ECCO: 2017 European Cancer Congress | ScienceDirect.com by Elsevier EJC | European Journal of Cancer | ECCO: 2017 European Cancer Congress | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0959804917X00038-cov200h.gif)
EJC | European Journal of Cancer | ECCO: 2017 European Cancer Congress | ScienceDirect.com by Elsevier
![European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine](https://kongres-magazine.eu/wp-content/uploads/2017/02/IMG_4737-800x600.jpg)
European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine
![Y-ECCO on X: "Peter Irving bravely tackling difficult realities of #ibd healthcare in cost limited times. Azathioprine monotherapy? Biosimilars? #ecco2017 https://t.co/o27RHHB5zr" / X Y-ECCO on X: "Peter Irving bravely tackling difficult realities of #ibd healthcare in cost limited times. Azathioprine monotherapy? Biosimilars? #ecco2017 https://t.co/o27RHHB5zr" / X](https://pbs.twimg.com/media/C4yzn03WEAMmMjc.jpg:large)
Y-ECCO on X: "Peter Irving bravely tackling difficult realities of #ibd healthcare in cost limited times. Azathioprine monotherapy? Biosimilars? #ecco2017 https://t.co/o27RHHB5zr" / X
![ECCO 2017: Women treated for precursor of breast cancer can expect to live as long as other women - ecancer ECCO 2017: Women treated for precursor of breast cancer can expect to live as long as other women - ecancer](https://cdn.ecancer.org/6973-m.jpg)
ECCO 2017: Women treated for precursor of breast cancer can expect to live as long as other women - ecancer
![ECCO2017: European Cancer Congress - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology ECCO2017: European Cancer Congress - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology](https://www.esp-pathology.org/_Resources/Persistent/d4f601fd211b016eed1346965cbbd8e92fa97881/ECCO2017%20600x450.png)